In the Reactome pathway enrichment analysis, the target genes were mainly enriched in 41 biological pathways (Supplementary Table S6), including many cancer-related metabolic pathways, e.g., ‘signaling by receptor tyrosine kinases’ (19 molecules), ‘signal transduction’ (52 molecules), and ‘signaling by FGFR3 fusions in cancer’ (2 molecules). The gene discussed is NTRK1; the disease is cancer.